These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12191761)

  • 1. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents.
    Vogel V; Sanchez C; Jennum P
    J Neurosci Methods; 2002 Jul; 118(1):89-96. PubMed ID: 12191761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats.
    Piper DC; Upton N; Smith MI; Hunter AJ
    Eur J Neurosci; 2000 Feb; 12(2):726-30. PubMed ID: 10712652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fluoromethylhistidine, a histamine synthesis inhibitor, inhibits orexin-induced wakefulness in rats.
    Yasuko S; Atanda AM; Masato M; Kazuhiko Y; Kazuki H
    Behav Brain Res; 2010 Feb; 207(1):151-4. PubMed ID: 19818811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem.
    Sunter D; Morgan I; Edwards CM; Dakin CL; Murphy KG; Gardiner J; Taheri S; Rayes E; Bloom SR
    Brain Res; 2001 Jul; 907(1-2):27-34. PubMed ID: 11430882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying obesity resistance associated with high spontaneous physical activity.
    Teske JA; Billington CJ; Kotz CM
    Neuroscience; 2014 Jan; 256():91-100. PubMed ID: 24161277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat.
    Smith MI; Piper DC; Duxon MS; Upton N
    Neurosci Lett; 2003 May; 341(3):256-8. PubMed ID: 12697296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin a elicits arousal electroencephalography without sympathetic cardiovascular activation in isoflurane-anesthetized rats.
    Yasuda Y; Takeda A; Fukuda S; Suzuki H; Ishimoto M; Mori Y; Eguchi H; Saitoh R; Fujihara H; Honda K; Higuchi T
    Anesth Analg; 2003 Dec; 97(6):1663-1666. PubMed ID: 14633539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness.
    Methippara MM; Alam MN; Szymusiak R; McGinty D
    Neuroreport; 2000 Nov; 11(16):3423-6. PubMed ID: 11095491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons.
    Satoh S; Matsumura H; Nakajima T; Nakahama K; Kanbayashi T; Nishino S; Yoneda H; Shigeyoshi Y
    Eur J Neurosci; 2003 Apr; 17(8):1635-45. PubMed ID: 12752381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG effect of orexin A in freely moving rats.
    Toth A; Balatoni B; Hajnik T; Detari L
    Acta Physiol Hung; 2012 Sep; 99(3):332-43. PubMed ID: 22982721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep.
    Verret L; Goutagny R; Fort P; Cagnon L; Salvert D; Léger L; Boissard R; Salin P; Peyron C; Luppi PH
    BMC Neurosci; 2003 Sep; 4():19. PubMed ID: 12964948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat.
    Xi MC; Morales FR; Chase MH
    Brain Res; 2001 May; 901(1-2):259-64. PubMed ID: 11368975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area.
    Uramura K; Funahashi H; Muroya S; Shioda S; Takigawa M; Yada T
    Neuroreport; 2001 Jul; 12(9):1885-9. PubMed ID: 11435917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central but not systemic administration of ghrelin induces wakefulness in mice.
    Szentirmai É
    PLoS One; 2012; 7(7):e41172. PubMed ID: 22815958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin.
    España RA; Plahn S; Berridge CW
    Brain Res; 2002 Jul; 943(2):224-36. PubMed ID: 12101045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased orexin expression promotes sleep/wake disturbances in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Liu R; Sheng ZF; Cai B; Zhang YH; Fan DS
    Chin Med J (Engl); 2015 Jan; 128(2):239-44. PubMed ID: 25591569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.